Evidence map›Paper›PMID 24968203›Full record

ArticleThe journal of spinal cord medicine2015

Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury.

Edyta Paczkowska, Dorota Rogińska, Ewa Pius-Sadowska, Alina Jurewicz, Katarzyna Piecyk, Krzysztof Safranow, Violetta Dziedziejko, Ryszard Grzegrzółka, Andrzej Bohatyrewicz, Bogusław Machaliński

Abstract read
In one paragraph

Article in The journal of spinal cord medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Edyta Paczkowska
Dorota Rogińska
Ewa Pius-Sadowska
Alina Jurewicz
Katarzyna Piecyk
Krzysztof Safranow
Violetta Dziedziejko
Ryszard Grzegrzółka
Andrzej Bohatyrewicz
Bogusław Machaliński

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CONTEXT/

objectiveTraumatic spinal cord injury (SCI) leads to disruption of local vasculature inducing secondary damage of neural tissue. Circulating endothelial progenitor cells (EPCs) play an important role in post-injury regeneration of vasculature, whereas endothelial cells (ECs) reflect endothelial damage.

methodsTwenty patients with SCI were assessed during the first 24 hours, at day 3, and day 7 post-injury and compared to 25 healthy subjects. We herein investigated EPC and EC counts by flow cytometry as well as the levels of soluble factors (SDF-1, HGF, VEGF, Ang2, EGF, endoglin, PLGF, FGF-2, ET-1, BDNF, IGF-1) regulating their migration and proangiogenic function. To better characterize peripheral blood (PB) cells, global gene expression profiles of PB-derived cells were determined using genome-wide RNA microarray technology.

resultsWe found significantly higher EPC (CD34(+)/CD133(+)/VEGFR2(+)) as well as EC (VEGFR2(+)) count in PB of patients with SCI within 7 days post-injury and the increased HGF, ET-1, Ang2, EGF, and PLGF plasma levels. Global gene expression analysis revealed considerably lower expression of genes associated with both innate and adaptive immune response in PB cells in patients.

conclusionCollectively, our findings demonstrate that SCI triggers bone marrow-derived EPC mobilization accompanied by increased circulating EC numbers. Significant changes in both chemoattractive and proangiogenic cytokines plasma levels occurring rapidly after SCI suggest their role in SCI-related regenerative responses to injury. Broadened knowledge concerning the mechanisms governing of human organism response to the SCI might be helpful in developing effective therapeutic strategies.

Indexed as

AC133 AntigenAdolescentAdultAgedAngiogenic ProteinsAntigens, CDAntigens, CD34Case-Control StudiesChemokine CXCL12Endothelial Progenitor CellsFemaleGlycoproteinsHumansMaleMiddle AgedPeptidesAC133 AntigenAngiogenic ProteinsAntigens, CDAntigens, CD34Chemokine CXCL12CXCL12 protein, humanGlycoproteinsKDR protein, humanPeptidesPROM1 protein, humanVascular Endothelial Growth Factor Receptor-2Angiogenic factorsEndothelial cellsEndothelial progenitor cellsImmune responseSpinal cord injury

Identifiers

PMID24968203
PMCPMC4725807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.